GENinCode (LON:GENI) Releases Earnings Results

GENinCode (LON:GENI) posted its quarterly earnings results on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%.

GENinCode Price Performance

GENI stock traded up GBX 0.04 during mid-day trading on Thursday, reaching GBX 0.73. The company’s stock had a trading volume of 2,103,826 shares, compared to its average volume of 5,110,390. The stock has a market cap of £5.53 million, a PE ratio of -0.35 and a beta of 0.59. The company’s 50 day moving average is GBX 0.88 and its two-hundred day moving average is GBX 0.98. GENinCode has a fifty-two week low of GBX 0.64 and a fifty-two week high of GBX 4.90. The company has a current ratio of 2.22, a quick ratio of 15.88 and a debt-to-equity ratio of 4.75.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.